Back to User profile » Professor Dirk Skowasch
Papers published by Professor Dirk Skowasch:
Characteristics of Older Individuals with Asthma Being Treated with Biologics
Aetou M, Kiskinov Y, Ratsimba SFN, Barth M, Pizarro C, Bergs I, Spiesshoefer J, Skowasch D, Dreher M
Journal of Asthma and Allergy 2025, 18:993-1002
Published Date: 11 June 2025
Blood Eosinophil Count in Asthma Is Associated With Increased Abdominal Aortic Diameter and Increased Vascular Stiffness
Biener L, Budimovska A, Skowasch D, Pizarro C, Frisch BC, Nickenig G, Stumpf MJ, Schaefer CA, Schahab N
Journal of Asthma and Allergy 2025, 18:245-255
Published Date: 20 February 2025
The Influence of Emphysema on Treatment Response to Biologic Therapy in Severe Asthma
Biener L, Morobeid H, Pizarro C, Kuetting D, Nickenig G, Skowasch D
Journal of Asthma and Allergy 2024, 17:1129-1140
Published Date: 8 November 2024
Maintenance OCS Were Used More Frequently Than Biologics in Patients with Uncontrolled GINA 4/5 Asthma in Germany in 2019
Milger K, Koschel D, Skowasch D, Timmermann H, Schmidt O, Bergmann KC, Neurohr C, Lindner R, Heck S, Virchow JC
Journal of Asthma and Allergy 2024, 17:1093-1101
Published Date: 1 November 2024
Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany
Timmermann H, Milger K, Virchow JC, Schmidt O, Bergmann KC, Koschel D, Neurohr C, Scholz F, Heck S, Skowasch D
Journal of Asthma and Allergy 2023, 16:813-820
Published Date: 4 August 2023
Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
Korn S, Milger K, Skowasch D, Schulz C, Mohrlang C, Wernitz M, Paulsson T, Hennig M, Buhl R
Journal of Asthma and Allergy 2023, 16:541-552
Published Date: 11 May 2023
Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany
Bergmann KC, Skowasch D, Timmermann H, Lindner R, Virchow JC, Schmidt O, Koschel D, Neurohr C, Heck S, Milger K
Journal of Asthma and Allergy 2022, 15:897-906
Published Date: 4 July 2022
Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2
Valipour A, Shah PL, Herth FJ, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Conway F, Duller M, Mayse M, Norman HS, Slebos DJ
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2807-2816
Published Date: 5 November 2020